Deciphering Biotech’s Peer-Reviewed Press Releases | $GTBP Set to Begin Phase II Clinical Trials in July, 2019.

Deciphering Biotech’s Peer-Reviewed Press Releases | $GTBP Set to Begin Phase II Clinical Trials in July, 2019.

When is comes to headhunting stocks, the biotech sector is an absolute breeding ground for growth opportunities.

Massive growth opportunities, but the caveat here isn’t so simple…

The real question is who actually has a technology that will make it to market in our immensely complicated healthcare system, and show profits for their endeavor?

There are more than a few variables that influence the successful launch of a new medical therapy/device.

Difficulty investing in the medical sector comes from one’s ability (or lack thereof) to discern quality science from quasi-experimental data.

Many times, press releases are written by the scientists themselves (or another equally experienced healthcare professional) and many of the details expressed by the company requires a Ph.D to decipher.

One sentence from $GTBP’s most recent press release is a perfect example.

One sentence…

In preclinical testing led by Dr. Jeffrey Miller, M.D., Deputy Director Masonic Cancer Center and Dr. Timothy Schacker, M.D., Medical School and Director, Program in HIV Medicine, the research team designed a series of Bispecific and Trispecific Natural Killer Cell Engagers (BiKE and TriKE) constructs to direct Natural Killer cell mediated cytotoxicity against an HIV infected target.

That my friends is a mouthful…

With so many references and nods, it’s hard to track what information is actually being disseminated.

Which brings me specifically to GT Biopharma, $GTBP.

Let me set the stage:

At the end of 2018 GT Biopharma presented positive data of their Tri-specific NK Cell Engager (TriKE) at the 60th American Society of Hematology (ASH) Annual Meeting.

Click here for the full article from December, 2018.

Positive results are good… but what’s better is when a company discovers something so potentially impactful that they completely restructure their management team to put the proper relationships in place.

What do I mean by proper relationships?

Mr. Cataldo already has a billion dollar company under his belt, and has proven himself to be a capable leader.

Anthony J Cataldo has been named Chairman and Chief Executive Officer. Mr. Cataldo founded and served as Chairman and Chief Executive Officer at Iovance Biotherapeutics, Inc. He created Iovance with assets purchased from the National Cancer Institute (NCI). Dr. Steven Rosenberg developed the autologous cell therapy technologies of the National Cancer Institute for the treatment of stage four melanoma. Iovance has a market capitalization over $1.3 billion.

Also take into account that this technology is on the cutting edge of science, and is a product of a very established university – The Masonic Cancer Center at the University of Minnesota.

Mr. Cataldo founded GT Biopharma on the NK cell technology developed by Dr. Jeffrey Miller, Director of the Masonic Cancer Center at the University of Minnesota. The NK cell technology was created for the treatment of solid and liquid tumors. Currently, two FDA clinical trials (phase one and phase two) are underway for the NK cell technology.

Now, what makes this technology so appealing is the scope of application.

Targeting both liquid and solid tumors significantly expands the marketing potential of such therapies.

Take into account a few recent acquisitions…

Most recently KITE Pharma was bought by Gilead Sciences, Inc. for $12 Billion (NASDAQ: GILD) and Juno Therpeautics was accuried ($9 Billion) by Celegene Corporation (NASDAQ: CELG). These highly expensive cell therapies are limited to only liquid tumors (20% of the cancer market).

These companies sold big, real big, and only serviced 20% of the cancer market.

Now let’s look at $GTBP’s most recent developments.

$GTBP just released positive results of their second phase trial in conjunction with the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 31 – June 4.

With the annual meeting concluding just one week ago, this information is still being digested by the medical community, and the company is continuing to move forward.

Mr. Anthony Cataldo, the Chairman and Chief Executive Officer of GT Biopharma commented: “GTB-1550 has shown positive results in its two Phase I-II clinical trials in advanced cancer patients who have failed all other therapies, and we are now planning to proceed with a Phase II clinical trial.”

That being said, we now have a forward looking date of when we expect more information to become available regarding this exciting breakthrough.

GTB-3550 (OXS-3550) is the Company’s first Tri-specific NK cell Engager (TriKE) product candidate being initially developed for the treatment AML. GTB-3550 (OXS-3550) is being readied to begin enrolling patients with advanced Acute Myeloid Leukemia (AML) in a Phase I/II expansion clinical trial starting mid- July 2019.

With a PhaseI/II clinical trial expansion beginning this July, expect more news and updates to come at lightening speeds.

If this therapy proves to be an effective cancer treatment for both solid and liquid tumors, and helps stifle the HIV epidemic… Look for $GTBP’s buyout options to dwarf those that only targeted 20% of the market.

Think about it… 🤔

You can read all of GT Biopharma’s Press Releases on their OTC Profile at: https://www.otcmarkets.com/stock/GTBP/news

Battle of the Bulls – $UBER $CRSM $LYFT| Can Carsmartt Overcome and Provide Solutions to Uber’s and Lyft’s Public Woes?

Battle of the Bulls – $UBER $CRSM $LYFT| Can Carsmartt Overcome and Provide Solutions to Uber’s and Lyft’s Public Woes?

Adrenaline.

Pure Adrenaline…

That’s how I’d describe the last week of trading for $CRSM.

We first reported on Carsmartt, Inc. in early March, back when speculations were high and the stock was largely still unknown.

At the beginning of May, we continued our coverage of Carsmartt, Inc. as they prepared to launch their new ride-sharing application…

Now, $CRSM has officially released their Rider’s and Driver’s application on Google Play and Apple iOS, and it looks slick!

I strongly recommend you download the app, and see for yourself.

Now, that being said…

No run is complete without it’s share of controversy, and the bashers are out in full force.

iHub is bubbling with banter from both sides of the isle. If you’re a supporter and decide to contribute to the conversation, expect to get hounded by one of three (if not all three) professional bashers. But I digress…

Visit the board and see for yourself.

Now one has to wonder…

Why would someone go out of their way, so consistently and agressively, to defame a company for so long if they didn’t have skin in the game? 🤔🤔

Seems to me it would be a huge waste of time unless you were strategically positioned to benefit from the negativity.

Thus a warning...

When browsing the boards, it’s important to keep things in perspective. Everyone posting has something to gain.

iHub isn’t the only influencer getting in on the action.

OTC Markets slapped a yield sign on $CRSM extremely late in the day on Tuesday.

You can see the impact this had on the stock directly. No question about it.

The yield sign was applied to their profile even though Carsmartt’s management was able to submit an updated filing that same day.

This culminated in three filings over the course of a week.

Though unfortunate, we have to welcome the strict regulations being enforced by the markets.

Now when you see a company listed on a specific market, it actually means something.

The OTC Markets drama seems to be short lived as we expect the yield sign to be removed at some point Tuesday following the holiday weekend.

Now it stands to be said…

Most companies in the OTC are lucky to get a single filing. Some tickers see a significant increase in price just because of an attorney letter…

Here we can see that CRSM’s management is extremely engaged and that builds confidence.

As for the bashers…

It’s a viscous process, but anyone who’s been around long enough has seen it play out time, and time again.

Even so, the negativity did not knock $CRSM off it’s feet.

You can see a nice, consistent scoop to end the week.

The smaller arrow points to a pattern which could arguably be interpreted as an inverted head and shoulders seen here…

The blue arrows point to a gap just off the second inverted shoulder. The gap was then immediately filled, and confirmed the reversal going into the long weekend.

At this time, not much has changed about $CRSM other than:

1) They now have a tangible product, and…

2) The act of discovery has begun.

There is still a considerable amount of speculation required to envision the future of CRSM, but what else can you expect?

The app has literally been out for less than a week on Apple iOS devices.

Everything we’ve seen over the past few months has been THE ground floor opportunity, and the ride of a lifetime has only begun.

$Uber and $Lyft have established the market, but their business models and practice only seem to cause controversy as of late.

$Carsmartt provides solutions.

If national media networks learn that $CRSM is aggressively pursuing $Uber’s and $Lyft’s customer base, the implications could be worth Billions.

Read our May 4th article here.

View $CRSM’s OTC Profile here.

Check our their iHub board here.

Follow us on Twitter @themoneyshire.

Taking Care of Man’s Best Friend | The Rise of #CBD in Pet Care

Taking Care of Man’s Best Friend | The Rise of #CBD in Pet Care

The pet care industry is one of the fastest growing sectors in the American economy. Each year, more and more money is spent on man’s best friend.

Combine that with the still untapped potential of the exploding #CBD market, and you have a recipe for success.

LinkResPet, a subsidiary of Link Reservations Inc. $LRSV, produces a line of CBD products specifically tailored for cats, dogs and horses.

Based in the UK, $LRSV is leading the way in product innovation. Just this month LinkResPet announced a new partnership to begin exploring #CBD water, and other aquaenrichment therapies.

(When I think about the importance of water quality in the horse racing industry, I can’t help but think they might be into something here…)

Water is THE absolute essential for life. It only makes sense to use it as a natural enhancer and remedy, and #CBD makes it possible.

$LRSV has proven to be at the bleeding edge, as today’s unknowns become tomorrow’s norms.

If $LRSV is able to market their product effectively and scale properly, their growth potential will be exponential in the days to come.

Weekend Update | $CRSM Focuses on Solutions While Uber Contends with Contentious Drivers

Weekend Update | $CRSM Focuses on Solutions While Uber Contends with Contentious Drivers

The question looms…

How is CarSmartt, Inc. still a penny stock?

Carsmartt, Inc. stays focused on providing solutions while Uber contends with contentious drivers

Carsmartt, Inc. is planning to disrupt a $100 billion dollar industry. Their new application is expected to rival Uber and Lyft, and potentially become a much-needed third option afforded to drivers and rider-sharers alike in the gig economy.

Competition is healthy, and many of the woes currently facing Uber and Lyft, the two titans of the ride-sharing sector, seem to stem from a lack of diversification. Limited choice and steep commissions plague the ride-sharing sector, and Carsmartt, Inc. is focused on being the solution.

UberUpset

https://nypost.com/2019/05/03/lyft-uber-drivers-planning-worldwide-strike-next-week/

Tensions are high amongst workers in the industry as they demand more rights and better pay from their overlords.

Even in controversy, Uber has an estimated IPO valuation of $90 billion dollars, but more on that in a minute…

This week has been a marathon of inquiry, investigation, and diligent fact finding. Carsmartt, Inc. has gone completely dark and information on their upcoming release is scarce.

The company has been very tight-lipped about their future endeavors.

Rumor has it they are consolidating their web presence and preparing to launch a new ride-sharing application that utilizes a coin-based wallet.

In the meantime however, this is all the information you get when you visit their website.

Not much to work with…

Thankfully the community has really stepped up and uncovered a treasure trove of goodies that you can use to familiarize yourself with Carsmartt, Inc. over the weekend.

As one of our members so eloquently put it:

Have you guys heard of amazon Flex? It’s people delivering amazon packages with their personal vehicles. Carsmartt is on the right track. This is why I poured money into it. They’re covering all the angles. With crypto adoption as well and their ico… It’s providing people with purchasing power.
They’re offering what people want. More pay. More payment Flexibility. And a variety of services so that drivers aren’t idle. Amazon is doing the same. [Uber and Lyft are also doing the same…]
There’s a new market, and there’s plenty of room For all companies to thrive. It’s not monopolized yet. And a piece of the pie is all we need.

To add to this point of “doing things right,” for this exact reason we see that Carsmartt may actually become a viable acquisition target in the near future. Though that is pure speculation at this time.

To make things easier, we have curated some relevant information for your viewing pleasure.

First and foremost, start with $CRSM’s application (that’s right, they already have a live beta-app) and social media profiles. As you can see they are very well put together and already have an established following.

Application:

[Note, I wouldn’t expect the beta version of the application to continue to function being that a newly updated app is about of officially launch.]

Facebook: https://www.facebook.com/carsmartt/

Twitter: https://twitter.com/car_smartt?lang=en

Instagram: https://www.instagram.com/carsmarttus/

Here’s some eye candy from their instagram.

[Original Content 05/03/2019]

When Carsmartt, Inc. launches their new ride-sharing application in the coming weeks, and if it functions as advertised, it’s going to be one of the most sought after companies in the OTC.

Since Carsmartt’s website is currently down for maintenance, members of our trading community have been scrambling to find information on the company.

Here are three items that require your attention:

  1. Most recent filing by the company with an emphasis on date May 1st of 2019: https://backend.otcmarkets.com/otcapi/company/financial-report/218573/content
  2. White Pages outlining the company vision: https://drive.google.com/file/d/1KmMk5PVTcsVsPEZHMYOE4PLGJZwJgpFY/view
  3. Informative Interview where Carsmartt rep explains their vision and points towards the future: https://m.youtube.com/watch?feature=youtu.be&v=iOMHxD9uZBY

Think about it…

As of writing this article, Lyft has a market capitalization of $15.5 Billion dollars, and Uber is rumored to have an estimated IPO valuation of $90 Billion.

A $90 billion dollar valuation for a company said to be losing money…

Now, it’s not unreasonable to suggest that $CRSM will engage with at least 1% (probably more) of the ride-sharing market over the next two years.

That’s right! For these valuations to work we’re focused on 1% engagement!

Even a measly one percent market share, assuming all things equal, would catapult Carsmartt’s market capitalization to One Billion Dollars.

That means we’re looking at an approximate price of $2.50 per share.

One percent of $100 billion dollars is substantial.

If their upcoming release even glimmers of success and has consistent adoption rates amongst drivers, we could see the price per share leave penny land permenantley.

…and the odds of them having a “successful” launch are pretty awesome.

It’s very probable that at least 10% of the ride-sharing market will register with Carsmartt to simply try the service and get first hand experience. Especially with Carsmartt promising 25% higher commission payouts to their drivers.

These higher payouts couldn’t have hit the market at a more attractive and lucrative time.

Uber drivers have been going on strike all over the world and Carsmartt may be the solution they’re looking for.

Additionally, emerging labor advocates are making competition stiffer than ever, and we believe Carsmartt will attract users and experience growth based on two key factors:

  1. Drivers are said to receive 25% more commissions for their work (as previously stated) and…
  2. Carmartt, Inc. utilizes a coin based wallet making their application and payment system seamless across international boarders.

In my personal opinion, it’s one of the most practical applications of blockchain technology to date.

So, not only does their primary application disrupt a $100 billion dollar ride-sharing industry, but they’re also building inherent value in a proprietary blockchain based currency.

Not to mention the potential for a self-driving fleet…

With that said, there’s a pretty good chance that Carsmartt will get a considerable amount of attention in the coming months.

There is even a chance that we’re witnessing the birth of the “big three” publicly traded ride-sharing corporations.

Only time will tell, but we are extremely excited to see what the future holds.

When official news from the company hits the wire, things could get very interesting, very quickly.

Check back for more information as updates become available, and for more information on $CRSM check out our introductory article here: https://moneyshire.com/2019/03/05/enjoy-the-ride-crsm-set-to-shine-this-spring/

P.S. We have reached out to the company for comment but they are not taking media requests at this time. We will update this article the moment more information becomes available.

Stay tuned…

Time to Shine [Update 5/3/2019] | $CRSM Starts Heating Up as Uber IPO draws near.

Time to Shine [Update 5/3/2019] | $CRSM Starts Heating Up as Uber IPO draws near.

When Carsmartt, Inc. launches their new ride-sharing application in the coming weeks, and if it functions as advertised, it’s going to be one of the most sought after companies in the OTC.

[Update 5/3/2019]

Since Carsmartt currently has their website down for maintenance, members of our trading community have been scrambling to find information on the company.

There are three items that require your attention…

  1. Most recent filing by the company on May 1st of 2019: https://backend.otcmarkets.com/otcapi/company/financial-report/218573/content
  2. White Pages outlining the company vision: https://drive.google.com/file/d/1KmMk5PVTcsVsPEZHMYOE4PLGJZwJgpFY/view
  3. Amazing interview where Carsmartt explains their vision and points towards the future: https://m.youtube.com/watch?feature=youtu.be&v=iOMHxD9uZBY

The future is now!

[Original Content 4/30/2019]

Think about it…

As of writing this article, Lyft has a market capitalization of $15.5 Billion dollars, and Uber is rumored to have an estimated IPO valuation of $90 Billion.

That’s right, a $90 Billion Dollar valuation for a company said to be losing money…

Now, It’s not unreasonable to suggest that $CRSM will engage at least 1% of the ride-sharing market over the next two years.

That’s right, we’re focused on 1% engagement.

Even a measly one percent market share, assuming all things equal, would catapult Carsmartt’s market capitalization to the Billion Dollar mark.

That means we’re looking at an approximate price of $2.50 per share.

One percent of $100 Billion dollars is substantial.

If their upcoming release even glimmers of success and has consistent adoption rates amongst drivers, we could see the price per share leave penny land for good.

…and the odds of them having a “successful” launch are pretty awesome.

It’s very probable that at least 10% of the ride-sharing market will register with Carsmartt to simply try the service and get first hand experience. Especially with Carsmartt promising 25% higher commission payouts to their drivers.

These higher payouts couldn’t have hit the market at a more attractive and lucrative time.

Uber drivers have been going on strike all over the world and Carsmartt may be the solution they’re looking for.

Additionally, emerging labor advocates are making competition stiffer than ever, and we believe Carsmartt will attract users and experience growth based on two key factors:

1) Drivers are said to receive 25% more commissions for their work (as previously stated) and…

2) Carmartt, Inc. utilizes a coin based wallet making their application and payment system seamless across international boarders.

In my personal opinion, it’s one of the most practical applications of blockchain technology to date.

So, not only does their primary application disrupt a $100 Billion dollar ride-sharing industry, but they’re also building inherent value in a proprietary blockchain based currency.

Not to mention the potential for a self-driving fleet…

With that said, there’s a pretty good chance that Carsmartt will get a considerable amount of attention in the coming months.

There is even a chance that we’re witnessing the birth of the “big three” publicly traded ride-sharing corporations.

Only time will tell, but we are extremely excited to see what the future holds.

When official news from the company hits the wire, things could get very interesting, very quickly.

Check back for more information as updates become available, and for more information on $CRSM check out our introductory article here: https://moneyshire.com/2019/03/05/enjoy-the-ride-crsm-set-to-shine-this-spring/

P.S. We have reached out to the company for comment but they are not taking media request at this time. We will update this article the moment more information becomes available.

Stay tuned…

[Update] Stock Report April 24th, 2019| Going Global with $GOIG

[Update] Stock Report April 24th, 2019| Going Global with $GOIG

[Update 4/24/19]

$GOIG is now Pink Current with the OTC markets. Check the picture proof…

Per the company’s previous press release, Ike (CEO) had a trip scheduled to visit Kenya and continue negotiations to begin producing and distributing cannabis from the country.

News looks hopeful that countries in the surrounding region are taking initiative to capitalize on the growing, freshly legalized industry, and Kenya is prime real estate on the equator with a bountiful labor market.

We look for corporate updates, shareholder information, and potential material events to be disclosed very, very soon.

Judging from the price action, anticipation is beginning to overflow and we could see a strong move north sooner rather than later.

[Update 4/19/19]

Here we go ladies and gentlemen!

Less than 24 hours from our $GOIG publication we see yet another update from the company. This is precisely the reason we choose to report on this type of action in the OTC.

$GOIG might have a checkered history, but learning how to spot an organizational turnaround is what separates good traders from the great.

It’s the ability to manage risk, and take early positions in epic trades.

Since we started following $GOIG we have seen the company go from a full on stop sign 🛑, dark and defunct, to one attorney letter away from being pink current.

Their profile is shaping up nicely.

With an updated TA we can confirm that all action in the stock has been retail. Though big, their share structure is solid and isn’t being diluted.

Having a larger float means that there is more liquidity in the stock.

Many OTC traders like low float plays because it can make the price action more volatile, and big gains can occur in a relatively short amount of time.

The downside to this strategy is it increases your likelihood of getting “stuck” in a position.

You might own 100K shares, but if only 10K sit on the bid you can’t sell without damaging the price. It can become a catch-22 at times and leaves traders staring a gains that can’t be fully realized.

Not so with $GOIG….

In fact, there is a whole clique of OTC traders that only trade large floats because it allows more money to flow through the stock.

Here’s $GOIG’s security details, updated as of yesterday.

Having a larger float means there is more opportunities to take large positions.

Depending on the size of your portfolio, it might not be worth the effort and fee to take a $100 position in a low floater.

Matching liquidity with position size is important to a well rounded trading strategy, and there is definitely a time and place for plays like $GOIG.

Now that the TA is verified, it adds even more transparency to $GOIG’s relationship with their shareholders.

These updates will pay off big over time as $GOIG earns the trust of more and more traders.

We expect to see more updates in near future, and look forward to reporting on what the company has in store for 2019.

This one is just getting started…

Original Content

Mastering the OTC is tricky business, especially with all the pumping, hyping, calling, bashing, promoting, whistleblowing, insider shenanigans, diluting, converting, and retweeting going on…

 

One sure fire way to cut through the static is with personal due diligence. Taking time to understand how a play should potentially develop is critical to becoming a successful micro-cap trader. By the time a stock in the OTC makes a move, it’s already over.  

 

You must buy when nobody else is buying or you’ll be stuck watching from the sidelines.

 

It’s important to always be thinking three steps ahead, and that is exactly why we continue to discuss one of our main spring swings, $GOIG.

 

Just as anticipated $GOIG posted their annual review on April 12th. They also had the stop sign removed from their OTCM profile as a result of submitting their annual review. 

 

So where do we go from here? What’s the usual process for bringing a company current, and what are the benefits of doing so? 

 

I’m glad you asked…

 

Follow this link for more information on the OTC markets designations.

 

Step one is to bring the company’s financial situation current with full disclosure listed on the OTC markets.

The OTC markets acknowledged this has been completed by removing the stop sign from $GOIG’s profile.

The following step is for a lawyer to draft a letter and sign off on the report to show that a third party has confirmed the report to be accurate and in good standing.

 

(The OTC markets will not just take any financial document without cause. Therefore, additional parties must be included in the process.)

 

Being in current standings with the OTC markets is crucial because it allows the company to start communicating freely with their shareholders and constituents.

With a stop sign in effect (or now in this case a yield) the company must be careful in open communications because it’s widely known that they are not making financial information public.

Investors do not have a reasonable opportunity to make educated decisions without financials. Period.

Too much communication and not enough disclosure will attract the dreaded CE badge, otherwise known as the buyer beware skull and crossbones, which can be a deadly blow to a stock’s potential.

 

In the case of $GOIG, we are seeing them move towards growth and approved communication.

 

The last release we saw mention of GoIP Global did not concern them directly, but was more a high-level look at developments in Africa as a whole. $GOIG had their name dropped because of the work they are doing in Kenya, but the press release itself was not directed towards $GOIG shareholders.

 

A marketing grey area to say the least…

 

But once $GOIG brings their OTC profile current, they can start communicating directly to shareholders, and begin to divulge more details regarding recent corporate developments. 

 

That’s when things will really start to heat up!

 

As it stands, all we really know are material facts from 2018, and that $GOIG is still in the early stages of revival.

As you can see from the filings this process began back in November of 2018 when multiple reports were submitted in short order, with the final filing closing out the 2018 calendar year being submitted just last week.

 

It’s a long, and tedious process…

 

So, ask yourself this. Would a company spend the time, money, and resources to embark on a six-month financial audit to bring their OTC market profile current for nothing? 

 

We at Moneyshire are of the mind that $GOIG has something to share with their constituents, but they must wait until their organization is properly aligned to do so.

If $GOIG jumps the gun and releases information too soon they could incur fines and have negative labels displayed on their profile, and that doesn’t bode well for anyone.

 

That said, $GOIG holds a HUGE amount of potential. Most can be derived from who we know is working with the company, and their reputations as deal makers.

 

In January Ike Sutton, CEO of GoIP Global, announced that Robert Hoban Esq. would be leading their advisory board. 

Here’s a little more about Robert, known as a “dealmaker” in the cannabis sector.

 There is no reason to believe that Robert and his team won’t get the job done.

The next huge catalyst building is their connection to Israel as mentioned here.

International trade is the name of the game.

 

To put it bluntly, we know that $GOIG has something big in the works and it involves cannabis. We’re talking international distribution big… and the team leading the charge is the best in the business. 

 

Shareholders need to be patient here. If a flood of updates came pouring in all at once, sure it would create a buying frenzy, but it would also create a sell off and the stock would never recover. 

 

Legitimate business takes time to develop, and even more time to execute. Since November of 2018 we have seen Ike and his team follow through with every single utterance, and there is no reason to think the trend won’t continue through 2019.

 

So buckle up, this one is just getting started.